The Norepinephrine Reuptake Inhibitor Reboxetine Alone Reduces Obstructive Sleep Apnea Severity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial
J Clin Sleep Med 2023 Jan 01;19(1)85-96, TJ Altree, A Aishah, KA Loffler, RR Grunstein, DJ EckertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.